[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Soft Tissue Allograft Market Report: Trends, Forecast and Competitive Analysis

July 2024 | 150 pages | ID: S9BE93C8621EEN
Lucintel

US$ 4,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Get it in 2 to 4 weeks by ordering today

The future of the soft tissue allograft market looks promising with opportunities in orthopedic, dentistry, and wounded care applications. The global soft tissue allograft market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are increasing demand for soft tissue allografts in athletics and other contact sports, increase in incidences of periodontal diseases among the young population, and rise in technological innovations in dental.

A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global soft tissue allograft market report, please download the report brochure.

In this market, cartilage allograft is the largest product segment of soft tissue allograft, whereas dentistry is the largest application. Growth in various segments of the soft tissue allograft market are given below:

The study includes trends and forecast for the global soft tissue allograft market by product type, application, end user, and region as follows:

By Product Type [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Cartilage Allograft
  • Tendon Allograft
  • Meniscus Allograft
  • Dental Allograft
  • Collagen Allograft
  • Amniotic Allograft
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Orthopedic
  • Dentistry
  • Wounded Care
  • Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Hospitals
  • Orthopedic Clinics
  • Dental Clinics
  • Ambulatory Service Centers
  • Aesthetic Centers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Spain
  • Germany
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • The Rest of the World
  • Brazil
Some of the soft tissue allograft companies profiled in this report include Arthrex, Zimmer Biomet, Integra LifeSciences Corporation, Lattice Biologics, Organogenesis, CONMED, Straumann, Osiris Therapeutics, Globus Medical, Alliqua BioMedical, Xtant Medical, B. Braun Melsungen, and C. R. Bard.

Lucintel forecasts that cartilage allograft will remain the largest product type segment over the forecast period due to increase in vascular and orthopedic surgeries, ACL surgeries, and other cosmetic surgeries.

Within this market, dentistry will remain the largest application segment over the forecast period, as soft tissue allograft are used to stop gum recession and to improve the appearance of the same. Soft tissues are also beneficial in curing periodontal disease and improve gum aesthetics.

North America will remain the largest region over the forecast period due to factors, such as increasing prevalence of diabetic foot ulcers, better healthcare awareness programs for diabetes, an increase in a number of surgical procedures on anterior cruciate ligament (ACL), technological development in dental implants, and increasing expenditure by major & small key players for the development of soft tissue allograft in the region.

Features of the Global Soft Tissue Allograft Market
  • Market Size Estimates: Global soft tissue allograft market market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global soft tissue allograft market size by various segments, such as product type, application, and end user in terms of value.
  • Regional Analysis: Global soft tissue allograft market breakdown by the North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product type, application, end user, and region for the global soft tissue allograft markett.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global soft tissue allograft market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions

Q.1 What are some of the most promising potential, high-growth opportunities for the global soft tissue allograft by product type (cartilage allograft, tendon allograft, meniscus allograft, dental allograft, collagen allograft, and amniotic allograft), application (orthopedic, dentistry, wounded care, and others), end user (hospitals, orthopedic clinics, dental clinics, ambulatory service centers, and aesthetic centers), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global soft tissue allograft market?
Q.5 What are the business risks and threats to the global soft tissue allograft market?
Q.6 What are the emerging trends in this soft tissue allograft market and the reasons behind them?
Q.7 What are some changing demands of customers in this soft tissue allograft market?
Q.8 What are the new developments in this soft tissue allograft market? Which companies are leading these developments?
Q.9 Who are the major players in this soft tissue allograft market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this soft tissue allograft market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global soft tissue allograft market?

Report Scope

Key Features Description

Base Year for Estimation 2019

Trend Period

(Actual Estimates) 2014-2019

Forecast Period 2020-2025

Pages More than 150

Market Representation / Units Revenue in US $ Million

Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling

Market Segments Product Type (Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft), Application (Orthopedic, Dentistry, Wounded Care, and Others), and End User (Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers),

Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)

Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY

2. MARKET BACKGROUND AND CLASSIFICATIONS

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T  2025

3.1: Macroeconomic Trends and Forecast
3.2: Global Soft Tissue Allograft Market Trends and Forecast
3.3: Global Soft Tissue Allograft Market by Product Type
  3.3.1: Cartilage Allograft
  3.3.2: Tendon Allograft
  3.3.3: Meniscus Allograft
  3.3.4: Dental Allograft
  3.3.5: Collagen Allograft
  3.3.6: Amniotic Allograft
3.4: Global Soft Tissue Allograft Market by Application
  3.4.1: Orthopedic
  3.4.2: Dentistry
  3.4.3: Wounded Care
  3.4.4: Others
3.5: Global Soft Tissue Allograft Market by End User
  3.5.1: Hospitals
  3.5.2: Orthopedic Clinics
  3.5.3: Dental Clinics
  3.5.4: Ambulatory Service Centers
  3.5.5: Aesthetic Centers

4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION

4.1: Global Soft Tissue Allograft Market by Region
4.2: North American Soft Tissue Allograft Market
  4.2.1: Market by Product Type: Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft
  4.2.2: Market by Application: Orthopedic, Dentistry, Wounded Care, and Others
  4.2.3: Market by End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers
  4.2.4: The United States Soft Tissue Allograft Market
  4.2.5: The Canadian Soft Tissue Allograft Market
  4.2.6: The Mexican Soft Tissue Allograft Market
4.3: European Soft Tissue Allograft Market
  4.3.1: Market by Product Type: Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft
  4.3.2: Market by Application: Orthopedic, Dentistry, Wounded Care, and Others
  4.3.3: Market by End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers
  4.3.4: The United Kingdom Soft Tissue Allograft Market
  4.3.5: The Spanish Soft Tissue Allograft Market
  4.3.6: The German Soft Tissue Allograft Market
  4.3.7: The French Soft Tissue Allograft Market
4.4: APAC Soft Tissue Allograft Market
  4.4.1: Market by Product Type: Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft
  4.4.2: Market by Application: Orthopedic, Dentistry, Wounded Care, and Others
  4.4.3: Market by End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers
  4.4.4: The Chinese Soft Tissue Allograft Market
  4.4.5: The Indian Soft Tissue Allograft Market
  4.4.6: The Japanese Soft Tissue Allograft Market
4.5: ROW Soft Tissue Allograft Market
  4.5.1: Market by Product Type: Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft, Collagen Allograft, and Amniotic Allograft
  4.5.2: Market by Application: Orthopedic, Dentistry, Wounded Care, and Others
  4.5.3: Market by End User: Hospitals, Orthopedic Clinics, Dental Clinics, Ambulatory Service Centers, and Aesthetic Centers
  4.5.4: Brazilian Soft Tissue Allograft Market

5. COMPETITOR ANALYSIS

5.1: Market Share Analysis
5.2: Product Portfoli  Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis

6. COST STRUCTURE ANALYSIS

6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin

7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS

7.1: Growth Opportunity Analysis
  7.1.1: Growth Opportunities for the Global Soft Tissue Allograft Market by Product Type
  7.1.2: Growth Opportunities for the Global Soft Tissue Allograft Market by Application
  7.1.3: Growth Opportunities for the Global Soft Tissue Allograft Market by End User
  7.1.4: Growth Opportunities for the Global Soft Tissue Allograft Market by Region
7.2: Emerging Trends in the Global Soft Tissue Allograft Market
7.3: Strategic Analysis
  7.3.1: New Product Development
  7.3.2: Capacity Expansion of the Global Soft Tissue Allograft Market
  7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Soft Tissue Allograft Market
  7.3.4: Certification and Licensing

8. COMPANY PROFILES OF LEADING PLAYERS

8.1: Arthrex
8.2: Zimmer Biomet
8.3: Integra LifeSciences Corporation
8.4: Lattice Biologics
8.5: Organogenesis
8.6: CONMED
8.7: Straumann
8.8: Osiris Therapeutics
8.9: Globus Medical
8.10: Alliqua BioMedical
8.11: Xtant Medical
8.12: B. Braun Melsungen
8.13: C. R. Bard


More Publications